Jazz Pharma Reports Q1 Epidiolex Sales Decreased 19% Sequentially to $157.9 Million

New Cannabis Ventures
By NCV NewswireMay 4, 2022, 9:00 pm385 pts
DUBLIN, May 4, 2022 /PRNewswire/ — Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced financial results for the first quarter of 2022, raised 2022 financial guidance and provided business updates. We’re pleased to raise our top- and bottom-line guidance, driven by our continued execution and…

Read Article Share
Share Article
- email
- twitter
- facebook
- pocket
- reddit
- tumblr
- linkedin
- pinterest

Trending Today on NewsBudz

The best products for Oil Day 2025 69

Delaware: Regulators Announce Adult Use Marijuana Sales to Begin Next Month 66

Medical Cannabis Companies Sue Kentucky Over Licensing Process 60

Gov. Signs Florida Law Allowing Revocation of Medical Cannabis Cards for Drug Crimes 58

House-Approved Veterans Affairs Budget Bill Ends Prohibition on Medical Cannabis Recommendations 57

Canada’s retail cannabis landscape continues to evolve 54

About NewsBudz

NewsBudz is your go-to app for daily cannabis news, covering everything from medical marijuana breakthroughs to recreational cannabis trends and legalization updates.

Our platform aggregates content from over 30 top-tier cannabis news outlets to deliver a curated stream of the latest headlines, insights, and developments across the marijuana and hemp industries.

Whether you're interested in policy reform, health research, cannabis business, CBD, delta 9 products or lifestyle stories, NewsBudz keeps you informed and connected. Accessible on the web and mobile, NewsBudz makes it easy to explore, read, and share cannabis news anytime, anywhere.